New York Study Alarmingly Finds That Most with Post COVID Brain Fog Have Damaged Blood Brain Barrier
Nikhil Prasad Fact checked by:Thailand Medical News Team Dec 27, 2025 1 hour, 56 minutes ago
Medical News: Disturbing Evidence Emerges From New York Researchers
A major study from New York has uncovered troubling evidence explaining why so many people continue to struggle with brain fog long after recovering from COVID-19. Researchers discovered that most patients with post COVID brain fog show signs of damage to the blood brain barrier, a critical defense system that protects the brain from harmful substances. This
Medical News report reveals how these hidden changes may be driving long-term cognitive problems in COVID survivors.
New York researchers warn that post COVID brain fog is linked to widespread blood brain barrier damage
and long-term cognitive risks
What Post COVID Brain Fog Really Means
Post COVID brain fog refers to persistent problems with memory, concentration, mental clarity, and confusion that last for more than one month after COVID-19 infection. Many patients describe feeling mentally slower, easily distracted, or unable to perform tasks they once handled with ease. Until now, these symptoms were often dismissed or poorly understood, leaving patients frustrated and without clear answers.
Institutions Behind the Study
The research was conducted by scientists and clinicians from NYU Grossman School of Medicine, NYU Alzheimer’s Disease Research Center, Center for Cognitive Neurology at New York University Langone Health, NYU College of Global Public Health, NYU Langone Hospitals, and the Vilcek Institute of Biomedical Science at New York University School of Medicine. These institutions collaborated to investigate the long-term neurological effects of COVID infections.
How the Researchers Investigated the Problem
The study examined 279 adults with no previous history of dementia or cognitive impairment. Among them, 228 had recovered from laboratory confirmed COVID, while 51 had never been infected. Blood samples were collected under fasting conditions and analyzed using advanced laboratory technology to measure inflammation, immune system activity, blood brain barrier integrity, and brain related proteins linked to memory loss. Participants also underwent standardized cognitive testing and received formal diagnoses from expert physicians.
Blood Brain Barrier Damage Identified
The most alarming finding was that individuals with post COVID brain fog had significantly higher levels of blood markers indicating increased blood brain barrier permeability. The blood brain barrier normally acts as a protective filter that prevents toxins and inflammatory substances from entering the brain. When this barrier becomes damaged or leaky, harmful molecules may cross into brain tissue and disrupt normal cognitive function.
At the same time, several immune signaling molecules were found to be lower in brain fog patients. Instead of showing ongoing inflammation, this pattern points to immune exhaustion, suggesting the immune system may be weakened and less capable of protecting the brain after inf
ection.
Warning Signs of Cognitive Decline
Among COVID survivors who were newly diagnosed with mild cognitive impairment, researchers identified elevated levels of abnormal tau proteins associated with Alzheimer’s disease. This suggests that COVID-19 related neurological damage may accelerate or expose early neurodegenerative processes in certain individuals.
Why These Findings Matter
The study provides clear biological evidence that post COVID brain fog is not psychological or imagined. Damage to the blood brain barrier, combined with immune exhaustion and abnormal brain protein changes, offers a strong explanation for why symptoms persist and why some patients experience progressive cognitive difficulties.
Final Conclusions
The findings strongly indicate that post COVID brain fog is associated with real and measurable brain damage involving the blood brain barrier and immune system dysfunction. These changes may increase long term vulnerability to cognitive decline and possibly future neurodegenerative disease, emphasizing the urgent need for early screening, long term monitoring, and targeted therapies aimed at restoring brain protection and immune balance in COVID-19 survivors.
The study findings were published in the peer reviewed journal: Alzheimer’s & Dementia.
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz70856_103583
For the latest COVID-19 news, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/coronavirus
https://www.thailandmedical.news/articles/long-covid
Share
Tweet
Share
